The analysis of the amount of circulating tumor cells (CTC) in the blood enables the controlling of a successful cancer therapy. The presence of those CTCs reflects a hint of the tumor growth and enables a method to monitor it. Unfortunately the concentration of CTCs in blood is quite low and to catch them is a rare event.

SYNENTEC’s imaging platforms (CELLAVISTA® and NYONE®) open a way to detect these rare events in a fast and reliable manner. The YT-Software® package uses embedded processing tools to pick the CTCs out of thousand blood cells to quantify them.

For further information look at ShortNote Rare Cells >